My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 618

    1.

    Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.

    Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.

    Diabetes. 2008 Jun;57(6):1712-22. Epub 2008 Feb 19.PMID: 18285555 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.

    Matsubara T, Abe H, Arai H, Nagai K, Mima A, Kanamori H, Sumi E, Takahashi T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.

    Lab Invest. 2006 Apr;86(4):357-68.PMID: 16482100 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.

    Mima A, Matsubara T, Arai H, Abe H, Nagai K, Kanamori H, Sumi E, Takahashi T, Iehara N, Fukatsu A, Kita T, Doi T.

    Lab Invest. 2006 Sep;86(9):927-39. Epub 2006 Jun 12.PMID: 16767106 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.

    Doi T, Mima A, Matsubara T, Tominaga T, Arai H, Abe H.

    Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S21-4. Epub 2008 Oct 7.PMID: 18842318 [PubMed - indexed for MEDLINE]Related articles

    5.

    Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.

    Yoshida S, Hashimoto T, Kihara M, Imai N, Yasuzaki H, Nomura K, Kiuchi Y, Tamura K, Ishigami T, Hirawa N, Toya Y, Kitamura H, Umemura S.

    Nephron Exp Nephrol. 2009;111(1):e20-30. Epub 2008 Dec 2.PMID: 19052474 [PubMed - indexed for MEDLINE]Related articles

    6.

    Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.

    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.

    Am J Physiol Renal Physiol. 2005 Oct;289(4):F911-21. Epub 2005 Jun 7.PMID: 15942051 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.

    Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.

    J Nephrol. 2003 Nov-Dec;16(6):841-9.PMID: 14736011 [PubMed - indexed for MEDLINE]Related articles

    8.

    Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.

    Okada M, Takemura T, Yanagida H, Yoshioka K.

    Kidney Int. 2002 Jan;61(1):113-24.PMID: 11786091 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

    Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

    FASEB J. 2000 Mar;14(3):439-47.PMID: 10698958 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.

    Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC.

    Kidney Int. 2000 Oct;58(4):1534-45.PMID: 11012888 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.

    Schwedler SB, Verbeke P, Bakala H, Weiss MF, Vilar J, Depreux P, Fourmaintraux E, Striker LJ, Striker GE.

    Diabetes Obes Metab. 2001 Aug;3(4):230-9.PMID: 11520302 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

    Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

    Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.PMID: 10859350 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.

    Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D.

    Kidney Int. 2003 Aug;64(2):451-8.PMID: 12846740 [PubMed - indexed for MEDLINE]Related articles

    14.

    Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.

    Nagai K, Matsubara T, Mima A, Sumi E, Kanamori H, Iehara N, Fukatsu A, Yanagita M, Nakano T, Ishimoto Y, Kita T, Doi T, Arai H.

    Kidney Int. 2005 Aug;68(2):552-61.PMID: 16014032 [PubMed - indexed for MEDLINE]Related articles

    15.

    C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.

    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.

    Nephrol Dial Transplant. 2005 Mar;20(3):532-8. Epub 2005 Jan 21.PMID: 15665028 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

    Mizuno S, Nakamura T.

    Am J Physiol Renal Physiol. 2004 Jan;286(1):F134-43. Epub 2003 Sep 30.PMID: 14519594 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.

    Cohen MP, Masson N, Hud E, Ziyadeh F, Han DC, Clements RS.

    Exp Nephrol. 2000 May-Jun;8(3):135-43.PMID: 10810230 [PubMed - indexed for MEDLINE]Related articles

    18.

    Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.

    Allen TJ, Cao Z, Youssef S, Hulthen UL, Cooper ME.

    Diabetes. 1997 Oct;46(10):1612-8.PMID: 9313758 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.

    Cohen MP, Lautenslager GT, Shearman CW.

    Metabolism. 2001 Dec;50(12):1435-40.PMID: 11735089 [PubMed - indexed for MEDLINE]Related articles

    20.

    Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.

    Moriyama T, Oka K, Ueda H, Imai E.

    Clin Exp Nephrol. 2004 Sep;8(3):230-6.PMID: 15480900 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity